Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Kirsten Bell-Burdett"'
Autor:
Michael R. Drumm, Wenxia Wang, Thomas K. Sears, Kirsten Bell-Burdett, Rodrigo Javier, Kristen Y. Cotton, Brynna Webb, Kayla Byrne, Dusten Unruh, Vineeth Thirunavu, Jordain Walshon, Alicia Steffens, Kathleen McCortney, Rimas V. Lukas, Joanna J. Phillips, Esraa Mohamed, John D. Finan, Lucas Santana-Santos, Amy B. Heimberger, Colin K. Franz, Jonathan Kurz, Jessica W. Templer, Geoffrey T. Swanson, Craig Horbinski
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 12 (2023)
Seizures are a frequent complication of adult-type diffuse gliomas, and are often difficult to control with medications. Gliomas with mutations in isocitrate dehydrogenase 1 or 2 (IDHmut) are more likely than IDH–wild type (IDHwt) gliomas to cause
Externí odkaz:
https://doaj.org/article/7fc24269c7a640d7a68744806d41d5ca
Publikováno v:
Ethnicity & Health. :1-12
Autor:
Michael Drumm, Wenxia Wang, Thomas K. Sears, Kirsten Bell-Burdett, Rodrigo Javier, Kristen Y. Cotton, Brynna T. Webb, Kayla T. Byrne, Dusten Unruh, Vineeth Thirunavu, Jordain Walshon, Alicia Steffens, Kathleen McCortney, Rimas V. Lukas, Joanna J. Phillips, Esraa Mohamed, John D. Finan, Lucas Santana-Santos, Amy B. Heimberger, Colin K. Franz, Jonathan E. Kurz, Jessica W. Templer, Geoffrey T. Swanson, Craig Horbinski
Publikováno v:
The Journal of clinical investigation, vol 133, iss 12
Seizures are a frequent complication of adult-type diffuse gliomas, and are often difficult to control with medications. Gliomas with mutations in isocitrate dehydrogenase 1 or 2 (IDHmut) are more likely than IDH-wild type (IDHwt) gliomas to cause se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::125e96da5b909fb444616a484ece9056
https://escholarship.org/uc/item/1hp8c54d
https://escholarship.org/uc/item/1hp8c54d
Autor:
Andrew B. Nixon, Federico Innocenti, Hanna K. Sanoff, Michael S. Lee, Dominic T. Moore, Anastasia Ivanova, Kouros Owzar, Chiara Cremolini, Alfredo Falcone, Richard M. Goldberg, Daniele Rossini, Federica Marmorino, Kelli Hammond, John C. Brady, Mark D. Starr, Ace J. Hatch, Alexander B. Sibley, Kirsten Bell Burdett, Jing Lyu, Yingmiao Liu
Regorafenib is a tyrosine kinase inhibitor approved by the FDA for the treatment of patients with chemotherapy refractory metastatic colorectal cancer (mCRC). Regorafenib inhibits signaling through multiple receptors associated with angiogenesis, met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cc13a6f6766962d7be65cf3e676a3ff
https://doi.org/10.1158/1535-7163.c.6542764
https://doi.org/10.1158/1535-7163.c.6542764
Autor:
Andrew B. Nixon, Federico Innocenti, Hanna K. Sanoff, Michael S. Lee, Dominic T. Moore, Anastasia Ivanova, Kouros Owzar, Chiara Cremolini, Alfredo Falcone, Richard M. Goldberg, Daniele Rossini, Federica Marmorino, Kelli Hammond, John C. Brady, Mark D. Starr, Ace J. Hatch, Alexander B. Sibley, Kirsten Bell Burdett, Jing Lyu, Yingmiao Liu
Figure S1, consort diagram. Table S1, pts characteristics. Table S2, baseline levels. Table S3, prognostic markers. Table S4, adjusted prognostic markers. Table S5, early changes. Table S6, late changes at disease progression.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e03a78e049b3b467e3d8a40989bca42
https://doi.org/10.1158/1535-7163.22520767
https://doi.org/10.1158/1535-7163.22520767
Autor:
Andrew B. Nixon, Michael J. Birrer, Robert A. Burger, Wei Deng, Matthew Boente, Keiichi Fujiwara, Jamie N. Bakkum-Gamez, Heidi Gray, David M. O'Malley, Krishnansu S. Tewari, Robert S. Mannel, Herbert I. Hurwitz, Heather A. Lankes, J. Chris Brady, Mark D. Starr, Yingmiao Liu, Alexander B. Sibley, David Tritchler, Kouros Owzar, Kirsten Bell Burdett, Angeles Alvarez Secord
The medians and ranges for all analytes at baseline.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfdb15a333993a7d4bcfda6d7564e9e2
https://doi.org/10.1158/1078-0432.22473075
https://doi.org/10.1158/1078-0432.22473075
Autor:
Andrew B. Nixon, Michael J. Birrer, Robert A. Burger, Wei Deng, Matthew Boente, Keiichi Fujiwara, Jamie N. Bakkum-Gamez, Heidi Gray, David M. O'Malley, Krishnansu S. Tewari, Robert S. Mannel, Herbert I. Hurwitz, Heather A. Lankes, J. Chris Brady, Mark D. Starr, Yingmiao Liu, Alexander B. Sibley, David Tritchler, Kouros Owzar, Kirsten Bell Burdett, Angeles Alvarez Secord
Purpose:GOG-0218, a double-blind placebo-controlled phase III trial, compared carboplatin and paclitaxel with placebo, bevacizumab followed by placebo, or bevacizumab followed by bevacizumab in advanced epithelial ovarian cancer (EOC). Results demons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c46078192db3ae0cddc44cbfc81d043
https://doi.org/10.1158/1078-0432.c.6528411.v1
https://doi.org/10.1158/1078-0432.c.6528411.v1
Autor:
Andrew B. Nixon, Michael J. Birrer, Robert A. Burger, Wei Deng, Matthew Boente, Keiichi Fujiwara, Jamie N. Bakkum-Gamez, Heidi Gray, David M. O'Malley, Krishnansu S. Tewari, Robert S. Mannel, Herbert I. Hurwitz, Heather A. Lankes, J. Chris Brady, Mark D. Starr, Yingmiao Liu, Alexander B. Sibley, David Tritchler, Kouros Owzar, Kirsten Bell Burdett, Angeles Alvarez Secord
Relationship between covariates and IL6.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::266a08394301daee8fdb58e7861c5bca
https://doi.org/10.1158/1078-0432.22473087.v1
https://doi.org/10.1158/1078-0432.22473087.v1
Autor:
Andrew B. Nixon, Michael J. Birrer, Robert A. Burger, Wei Deng, Matthew Boente, Keiichi Fujiwara, Jamie N. Bakkum-Gamez, Heidi Gray, David M. O'Malley, Krishnansu S. Tewari, Robert S. Mannel, Herbert I. Hurwitz, Heather A. Lankes, J. Chris Brady, Mark D. Starr, Yingmiao Liu, Alexander B. Sibley, David Tritchler, Kouros Owzar, Kirsten Bell Burdett, Angeles Alvarez Secord
Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13a83f6259c9f2a856f3b2d3b4515392
https://doi.org/10.1158/1078-0432.22473081.v1
https://doi.org/10.1158/1078-0432.22473081.v1
Autor:
Andrew B. Nixon, Michael J. Birrer, Robert A. Burger, Wei Deng, Matthew Boente, Keiichi Fujiwara, Jamie N. Bakkum-Gamez, Heidi Gray, David M. O'Malley, Krishnansu S. Tewari, Robert S. Mannel, Herbert I. Hurwitz, Heather A. Lankes, J. Chris Brady, Mark D. Starr, Yingmiao Liu, Alexander B. Sibley, David Tritchler, Kouros Owzar, Kirsten Bell Burdett, Angeles Alvarez Secord
3-way interaction analyses between outcome, treatment, and markers.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d75ad55214ccd31b624b3f412800b92
https://doi.org/10.1158/1078-0432.22473084.v1
https://doi.org/10.1158/1078-0432.22473084.v1